United States Biotechnology & Medical Research

CNS Pharmaceuticals Inc (CNSP)

Track

Over the past 90 days, CNS Pharmaceuticals Inc. recorded one insider transaction, consisting of a purchase valued at $34,001.90 by an insider. This activity follows a period where the stock price declined by 18.6%. The company's next earnings report is scheduled for August 13, 2026, following the most recent release on August 13, 2025.
Ticker: CNSP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CNS Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Charles Faith L. Non-Executive Director
Transaction date
Purchase
Price
60.63
Quantity 264 -20.3%
Value US$2,013,563
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
416.48
Quantity 19,380 -3.4%
Value US$4,170,183
Evans Carl Anthony Non-Executive Director
Transaction date
Purchase
Price
498.97
Quantity 93,313 -16.5%
Value US$4,084,052
3.5
Gumulka Jerzy Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 33,333 +344.6%
Value US$10,000
3.3
Climaco John M Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.30
Quantity 166,666 +340.1%
Value US$50,000
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
1.27
Quantity 27,000 +276.3%
Value US$34,177
3.3
Climaco John M Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.80
Quantity 2,750 +5.9%
Value US$4,944
3.5
Gumulka Jerzy Non-Executive Director
Transaction date
Purchase
Price
1.70
Quantity 2,500 +34.9%
Value US$4,250
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
3.20
Quantity 3,100 +50.4%
Value US$9,920
3.3
Climaco John M Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.69
Quantity 15,000 +50.0%
Value US$10,408
3.5
Gumulka Jerzy Non-Executive Director
Transaction date
Purchase
Price
0.74
Quantity 7,173 +inf%
Value US$5,308
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.04
Quantity 10,000 -6.0%
Value US$10,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.09
Quantity 5,000 -2.9%
Value US$5,450
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 5,000 -2.8%
Value US$5,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 10,000 -5.4%
Value US$10,800
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 5,000 -2.6%
Value US$5,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.10
Quantity 5,000 -2.5%
Value US$5,500
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 5,000 -2.5%
Value US$5,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.13
Quantity 5,000 -2.4%
Value US$5,650
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.24
Quantity 5,000 -2.4%
Value US$6,200
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.22
Quantity 5,000 -2.3%
Value US$6,100
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.35
Quantity 5,000 -2.3%
Value US$6,750
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.30
Quantity 5,000 -2.2%
Value US$6,500
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.29
Quantity 5,000 -2.2%
Value US$6,450
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.43
Quantity 2,798 -1.2%
Value US$6,799
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.40
Quantity 5,500 -2.3%
Value US$13,200
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.46
Quantity 5,500 -2.2%
Value US$13,530
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.47
Quantity 5,500 -2.2%
Value US$13,585
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
0.94
Quantity 5,000 +3.4%
Value US$4,702
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
1.15
Quantity 4,500 +3.2%
Value US$5,192
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
2.04
Quantity 142,000 +inf%
Value US$289,680
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-18 B Purchase
3.1
Charles Faith L.
Non-Executive Director
264 -20.3%
60.63
US$2,013,563 		264 -20.3% 60.63 US$2,013,563
2024-02-06 2024-02-01 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
19,380 -3.4%
416.48
US$4,170,183 		19,380 -3.4% 416.48 US$4,170,183
2024-02-06 2024-02-01 B Purchase
Evans Carl Anthony
Non-Executive Director
93,313 -16.5%
498.97
US$4,084,052 		93,313 -16.5% 498.97 US$4,084,052
2024-02-06 2024-02-01 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
33,333 +344.6%
0.30
US$10,000 		33,333 +344.6% 0.30 US$10,000
2024-02-06 2024-02-01 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
166,666 +340.1%
0.30
US$50,000 		166,666 +340.1% 0.30 US$50,000
2023-08-23 2023-08-22 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
27,000 +276.3%
1.27
US$34,177 		27,000 +276.3% 1.27 US$34,177
2023-08-16 2023-08-16 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
2,750 +5.9%
1.80
US$4,944 		2,750 +5.9% 1.80 US$4,944
2023-04-21 2023-04-19 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
2,500 +34.9%
1.70
US$4,250 		2,500 +34.9% 1.70 US$4,250
2023-04-18 2023-04-17 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
3,100 +50.4%
3.20
US$9,920 		3,100 +50.4% 3.20 US$9,920
2023-04-14 2023-04-12 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
15,000 +50.0%
0.69
US$10,408 		15,000 +50.0% 0.69 US$10,408
2023-04-17 2023-04-10 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
7,173 +inf%
0.74
US$5,308 		7,173 +inf% 0.74 US$5,308
2023-08-01 2023-03-28 S Sale
1.6
Priebe Waldemar
Large shareholder
10,000 -6.0%
1.04
US$10,400 		10,000 -6.0% 1.04 US$10,400
2023-08-01 2023-03-27 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.9%
1.09
US$5,450 		5,000 -2.9% 1.09 US$5,450
2023-08-01 2023-03-24 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.8%
1.08
US$5,400 		5,000 -2.8% 1.08 US$5,400
2023-08-01 2023-03-23 S Sale
1.6
Priebe Waldemar
Large shareholder
10,000 -5.4%
1.08
US$10,800 		10,000 -5.4% 1.08 US$10,800
2023-08-01 2023-03-22 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.6%
1.08
US$5,400 		5,000 -2.6% 1.08 US$5,400
2023-08-01 2023-03-21 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.5%
1.10
US$5,500 		5,000 -2.5% 1.10 US$5,500
2023-08-01 2023-03-20 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.5%
1.08
US$5,400 		5,000 -2.5% 1.08 US$5,400
2023-08-01 2023-03-17 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.4%
1.13
US$5,650 		5,000 -2.4% 1.13 US$5,650
2023-08-01 2023-03-16 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.4%
1.24
US$6,200 		5,000 -2.4% 1.24 US$6,200
2023-08-01 2023-03-15 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.3%
1.22
US$6,100 		5,000 -2.3% 1.22 US$6,100
2023-08-01 2023-03-14 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.3%
1.35
US$6,750 		5,000 -2.3% 1.35 US$6,750
2023-08-01 2023-03-13 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.2%
1.30
US$6,500 		5,000 -2.2% 1.30 US$6,500
2023-08-01 2023-03-10 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.2%
1.29
US$6,450 		5,000 -2.2% 1.29 US$6,450
2023-08-01 2022-12-09 S Sale
1.6
Priebe Waldemar
Large shareholder
2,798 -1.2%
2.43
US$6,799 		2,798 -1.2% 2.43 US$6,799
2023-08-01 2022-12-08 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.3%
2.40
US$13,200 		5,500 -2.3% 2.40 US$13,200
2023-08-01 2022-12-07 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.2%
2.46
US$13,530 		5,500 -2.2% 2.46 US$13,530
2023-08-01 2022-12-06 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.2%
2.47
US$13,585 		5,500 -2.2% 2.47 US$13,585
2021-12-07 2021-12-06 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
5,000 +3.4%
0.94
US$4,702 		5,000 +3.4% 0.94 US$4,702
2021-11-22 2021-11-19 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
4,500 +3.2%
1.15
US$5,192 		4,500 +3.2% 1.15 US$5,192
2020-08-25 2020-08-24 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
142,000 +inf%
2.04
US$289,680 		142,000 +inf% 2.04 US$289,680
Explore more

More insider trading research around CNS Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America